Corvus Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Corvus Pharmaceuticals, Inc. has filed 570 SEC EDGAR filings since 08 Dec 2014

SEC filing history

Showing 76-100 of 570 matching filings.

Per page
25
Current page
4
EFFECT File 333-281318

EFFECT filing

Filing date
15 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-281318

UPLOAD filing

Filing date
13 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-281318

S-3

Filing date
06 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89443

SC 13G/A filing

Filing date
01 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 May 2024
Reporting date
10 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89443

SC 13G/A filing

Filing date
13 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89443

CORVUS PHARMACEUTICALS, INC.

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 May 2024
Reporting date
06 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 May 2024
Reporting date
06 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89443

AMENDMENT NO. 9

Filing date
08 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-279189

S-8

Filing date
07 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 May 2024
Reporting date
06 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 May 2024
Reporting date
06 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .